| Patents for C07D 515 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (877) |
|---|
| 01/22/2009 | CA2693533A1 Macrocyclic indole derivatives for the treatment of hepatitis c infections |
| 12/23/2008 | US7468377 Imidazopyridine-derivatives as inductible no-synthase inhibitors |
| 12/23/2008 | US7468376 Pyrazolopyridine derivates |
| 12/16/2008 | US7465743 Pyrazolo[3,4-b]pyridine compounds, and their use as PDE4 inhibitors |
| 12/16/2008 | US7465741 selective serotonine (5-HT) reuptake inhibitor activity in combination with additional alpha 2-adrenocptor antagonist activity; To treat anxiety, movement disorders, psychosis, Parkinson's disease and body weight disorders including anorexia nervosa and bulimia without being sedative |
| 12/10/2008 | EP1467735B1 Polymorphs of clopidogrel hydrogensulfate |
| 12/02/2008 | US7459463 Crystalline forms of 2,3-dimethyl-8-(2,6-dimethylbenzylamino)-N-hydroxyethyl-imidazo[1,2-a] pyridine-6-carboxamide mesylate salt |
| 12/02/2008 | US7459451 Pyrazolopyridine derivatives |
| 11/20/2008 | WO2008140420A2 Pyrimidine derivatives |
| 11/18/2008 | US7452993 morpholin-4-yl-{3-[3-(1H-pyrazol-4-yl)-1H-pyrazolo[3,4-b]pyridin-5-yl-phenyl}-methanone; FMS-like tyrosine kinase 3 (FLT3), is implicated in cancers, including leukemia, such as acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), and myelodysplasia |
| 11/04/2008 | US7446113 the prodrug forms of compounds have good absorption, pharmacokinetics, distribution and transport to the brain; 4-[8-Trifluoromethyl-6-(4-trifluoromethyl-phenyl)-imidazo[1,2-a]pyridin-3-ylethynyl]-benzenesulfonamide; nervous system disorders like psychosis, schizophrenia, Alzheimer's disease, depression |
| 10/30/2008 | WO2008016648A3 Certain chemical entities, compositions and methods |
| 10/22/2008 | EP1981342A1 Selective benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors |
| 10/22/2008 | EP1554284B1 Method for manufacturing crystalline form i of clopidogrel hydrogen sulphate |
| 10/22/2008 | CN101289455A Anti-influenza virus precursor drug and uses thereof |
| 10/14/2008 | US7435820 Substituted tetrahydro-1H-pyrazolo [3,4-c]pyridines compositions comprising them, and use |
| 10/07/2008 | US7432375 JNK inhibitors |
| 10/07/2008 | US7432278 Dicationic imidazo[1,2-a]pyridines and 5,6,7,8-tetrahydro-imidazo[1,2-a]pyridines as antiprotozoal agents |
| 09/25/2008 | WO2008115381A1 Pyridazinone derivatives useful as glucan synthase inhibitors |
| 09/25/2008 | US20080234279 Ecteinascidins |
| 09/25/2008 | CA2680583A1 Pyridazinone derivatives useful as glucan synthase inhibitors |
| 09/23/2008 | US7427682 Indole derivatives as selective androgen receptor modulators (SARMS) |
| 09/18/2008 | US20080227975 Method of producing fr901228 |
| 09/17/2008 | CN101265262A New oxabispidine compounds useful in the treatment of cardiac arrhythmias |
| 09/16/2008 | US7425629 Stereoselective synthesis of certain trifluoromethyl-substituted alcohols |
| 09/10/2008 | EP1965824A2 Metabolite derivatives of the hdac inhibitor fk228 |
| 09/04/2008 | WO2008105526A1 Macrocyclic compound |
| 09/04/2008 | CA2679126A1 Macrocyclic compound |
| 08/28/2008 | WO2008101665A1 Macrocyclic compounds as hcv ns3 protease inhibitors |
| 08/28/2008 | CA2677843A1 Macrocyclic compounds as hcv ns3 protease inhibitors |
| 08/26/2008 | US7417145 Process for total synthesis of ecteinascidins and intermediates therefor |
| 08/26/2008 | US7417053 Pyrazolo[1,5-a]pyridine derivatives or pharmaceutically acceptable salts thereof |
| 08/26/2008 | US7417052 Phenylene derivative having tetrazole ring or thiazolidinedione ring |
| 08/21/2008 | WO2007092641A3 Method for substituted 1h-imidazo[4,5-c]pyridines |
| 08/12/2008 | US7410969 Antitumoral analogs of ET-743 |
| 08/05/2008 | CA2331593C Metabolites of ecteinascidin 743 |
| 08/05/2008 | CA2286796C Nucleophile substituted ecteinascidins and n-oxide ecteinascidins |
| 07/29/2008 | US7405302 5-lipoxygenase-activating protein (FLAP) inhibitors |
| 07/29/2008 | US7405225 Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses |
| 07/22/2008 | US7402593 (-)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]imidazo[4,5-b]pyridine; proton pump inhibitor (PPI) to treat gastro-oesophageal reflux, digestive bleeding and dyspepsia; enantiomer; long duration of action; longer half-life in plasma; oxidation of sulfide followed by salt formation |
| 07/17/2008 | WO2008020405A3 Azetidine compounds as orexin receptor antagonists |
| 07/15/2008 | US7399765 Substituted diazabicycloalkane derivatives |
| 07/08/2008 | US7396932 Fusing a N-phenyl-C-leaving group-C-carbonyl- or oxycarbonylhydrazide with a 1-(p-nitrophhenyl)-3-halo-tetrahydro-2-piperidone; subsequent reactions include reduction and amidation of the nitro group and amidation of carbonyl or ester group; final products include factor Xa inhibitors |
| 07/01/2008 | US7393954 Process for the production of pentostatin aglycone and pentostatin |
| 06/26/2008 | WO2008075103A1 Antiviral indoles |
| 06/26/2008 | CA2672250A1 Antiviral indoles |
| 06/19/2008 | US20080146580 Anititumoral Ecteinascidin Derivatives |
| 06/17/2008 | US7388096 Crystalline forms of a factor Xa inhibitor |
| 06/17/2008 | US7388010 fused hexacyclic derivatives consist of pyrrolidine, indazolone, quuinoxalinone rings; cyclin-dependent kinase inhibitor with cell growth-inhibitory activity; anticarcinogenic and antiproliferative agent |
| 06/12/2008 | US20080139529 Nervous system, neurodegenerative, psychiatric, sexual, attention deficit, and psychological disorders; cognition activators, antidepressants, anxiolytic agents; alcoholism, drug abuse, traumas, strokes, epilepsy, schizophrenia, autism, and/or Alzheimer's disease treatment |
| 06/11/2008 | CN100393726C Process for preparing 2,4-disubstituted heterocyclo [4,5-e][1,2,4] thiadiazine derivatives |
| 05/13/2008 | US7371864 3-(1-hydroxy-1-methyl-ethyl)-1-(4-methoxy-phenyl)-6-[4-(2-oxo-2H-pyridin-1-yl)-phenyl]-1,4,5,6-tetrahydro-pyrazolo[3,4-c]pyridin-7-one for treating thromboembolic disorders |
| 05/06/2008 | CA2327468C Semi-synthetic ecteinascidins |
| 04/30/2008 | CN100384856C Heterocyclic cyclopentyl tetrahydroisoquinoline and tetrahydropyridopyridine modulators of chemokine receptor activity |
| 04/09/2008 | CN100379743C New oxabispidine compound useful in treatment of cardiac arrhythmias |
| 04/01/2008 | US7351821 Oxabispidine compounds useful in the treatment of cardiac arrhythmias |
| 03/27/2008 | US20080076794 Hyperaldosteronism |
| 03/19/2008 | EP1399450B1 Benzoxazepine derivatives and their use as ampa receptor stimulators |
| 03/19/2008 | EP1363630B1 Kappa opioid receptor ligands |
| 03/19/2008 | CN101146807A Process for preparing 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-C][1,5]naphthyridin-4-amine |
| 02/28/2008 | US20080051407 These compounds lack a 1,4-bridging group as found in the ecteinascidins; and, have at the C-1 position a substituent selected from an amino or hydroxy group, optionally protected or derivatized; anticarcinogenic agents |
| 02/21/2008 | WO2007136746A3 Macrocyclic compounds and their uses as stearoyl-coa desaturase |
| 02/21/2008 | US20080045713 Tetrahydroisoquinolinedione derivative intermediates for the hemisynthesis of ecteinascidin or other tetrahydroisoquinolinephenol compounds |
| 02/21/2008 | CA2659299A1 Azetidine compounds |
| 02/20/2008 | EP1414828B9 Antitumoral analogs |
| 02/12/2008 | US7329677 2-[3-(4-Methoxypyridin-2-yl)prop-2-yl]-3H-imidazo[4,5-b]pyridine hydrochloride; transcriptional activation of the iNOS-promoter, tissue and organ damage, cytotoxicity reduction |
| 02/05/2008 | US7326705 2-amino or carbonylamino-4-carbocyclic imidazoles and thiazoles; antiischemic agents, hypotensive agents, antiarrhythmia agents; can be coadministered with other drugs |
| 01/29/2008 | US7323569 N-cyclopropylmethyl-N-7-[2,6-dimethoxy-4-(methoxymethyl)phenyl]-2-ethylpyrazolo[1,5-a]pyridin-3-yl-N-tetrahydro-2H-4-pyranylmethylamine. |
| 01/22/2008 | US7321040 MAP (mitogen-activated protein) kinase inhibitors; osteoarthritis, rheumatoid arthritis, anticarcinogenic or antiischemic agents; reperfusion injuries, strokes or heart attack; autoimmune, skin, cardiovascular, brain, bone, neurodegenerative, respiratory system and nervous system disorders |
| 01/17/2008 | WO2008007661A1 Tricyclic heterocyclic compound and use thereof |
| 01/09/2008 | EP1876180A2 Semi-synthetic ecteinascidins |
| 01/09/2008 | EP1874768A2 Inhibitors of akt activity |
| 01/03/2008 | US20080004262 2,2,7,9-tetramethyl-4-[(2-phenylethyl)amino]-3,4-dihydro-2H-pyrano[2,3-g]quinolin-3-ol; 3-hydroxy-2,2,9-trimethyl-4-[(2-phenylethyl)amino]-3,4-dihydro-2H-pyrano[2,3-g]quinolin-7-carbonitrile; have the prolongation effect on refractory period |
| 01/01/2008 | US7314936 antiinflammatory agents; 1H-imidazo[4,5-b]pyridin-7-indole-2-yl- derivatives; autoimmune and proliferative disorders; inhibitors of cell adhesion molecule expression and inflammatory cytokine signal transduction; rheumatoid arthritis, ulcerative colitis/Crohn's disease, central nervous system diseases |
| 12/26/2007 | CN100357295C Macrocyclic pyrimidines, their production and use as pharmaceutical agents |
| 12/11/2007 | US7307073 Benzoxazepines derivatives and their use as AMPA receptor stimulators |
| 11/29/2007 | US20070275942 Compositions and Uses of Et 743 for Treating Cancer |
| 11/14/2007 | EP1854800A1 Antitumoral derivatives of Ecteinascidin ET-743 |
| 11/13/2007 | US7294715 E.g., 2,9-Diisopropyloxy-1,10-dimethoxy-7-oxoaporphine and 1-methoxy-2-hydroxy-9,10-methylenedioxyaporphine; are used to treat ischemic and metabolic diseases |
| 11/06/2007 | US7291733 pyrido[3',2':4,5]thieno[3,2-d]-pyrimidines (or triazines or pyridines); inhibitors of the kinase activity of the I kappa B kinase (IKK) complex; autoimmune diseases, inflammatory diseases and cancer; lupus, rheumatoid arthritis, breast canser |
| 10/30/2007 | US7288655 α v integrin receptor antagonists |
| 10/23/2007 | US7285666 Pyrazolo[1,5-a] pyridines and medicines containing the same |
| 10/17/2007 | CN100343235C Nucleophile substituted ecteinascidins and N-oxide ecteinsacidins |
| 10/11/2007 | US20070238747 Rifamycin analogs and uses thereof |
| 10/03/2007 | EP1838152A2 Imidazolylmethyl and pyrazolylmethyl heteroaryl derivatives |
| 10/03/2007 | EP1414828B1 Antitumoral analogs |
| 09/26/2007 | CN100339375C Metabolites of ecteinascidin 743 |
| 09/19/2007 | EP1833827A2 Process for preparing 2-methyl-1-(2-methylpropyl)-1h-imidazoý4,5-c¨ý1,5¨naphthyridin-4-amine |
| 09/06/2007 | US20070207973 1,3,5-Triazines for Treatment of Viral Diseases |
| 09/05/2007 | EP1828181A2 Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2m3-b]pyrimidin-4-yl-amines as janus kinase inhibitors |
| 08/30/2007 | WO2006113837A3 Inhibitors of akt activity |
| 08/29/2007 | EP1406907B1 Antitumoral derivatives of et-743 |
| 08/29/2007 | CN100334094C Antitumoral analogs |
| 08/16/2007 | WO2006074046A3 Process for preparing 2-methyl-1-(2-methylpropyl)-1h-imidazo[4,5-c][1,5]naphthyridin-4-amine |
| 08/15/2007 | EP1067933B1 Semi-synthetic ecteinascidins |
| 08/14/2007 | US7256293 Imidazopyridine intermediates |
| 08/07/2007 | USRE39762 e.g. 13-desmethoxy-18-hydroxyl-FK-520; compounds of the invention may be administered to achieve immunosuppression or to stimulate nerve growth and regeneration |
| 07/24/2007 | US7247629 Antitumoral analogs of et-743 |
| 07/12/2007 | WO2006009718A3 Methods for treating or preventing erectile dysfunction or urinary incontinence |
| 07/11/2007 | EP1806349A1 Antitumoral analogs |